Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 916 studies with search of: | United States, New Hampshire |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Active, not recruiting |
Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial CAN-NCIC-MA27
|
||||
2 | Recruiting |
Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer
|
||||
3 | Recruiting |
Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
|
||||
4 | Recruiting |
Combination Chemotherapy in Treating Women With Breast Cancer
|
||||
5 | Recruiting |
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
|
||||
6 | Recruiting |
Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer
|
||||
7 | Active, not recruiting |
Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole
|
||||
8 | Recruiting |
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
|
||||
9 | Recruiting |
Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
|
||||
10 | Active, not recruiting |
Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer
|
||||
11 | Recruiting |
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
|
||||
12 | Recruiting |
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
|
||||
13 | Active, not recruiting |
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
|
||||
14 | Recruiting |
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
|
||||
15 | Recruiting |
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
|
||||
16 | Recruiting |
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
|
||||
17 | Active, not recruiting |
Hormone Therapy With or Without Mitoxantrone and Prednisone in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
|
||||
18 | Recruiting |
Letrozole After Tamoxifen in Treating Women With Breast Cancer
|
||||
19 | Active, not recruiting |
Bortezomib and Liposomal Doxorubicin in Treating Patients With Multiple Myeloma
|
||||
20 | Recruiting |
Anastrozole With or Without Fulvestrant as First-Line Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer
|
Previous Page | Studies Shown (1-20) | Next (21-40) |